John H. Rex is a physician and drug developer with more than 30 years of development and policy experience focused on antimicrobial agents. He has extensive experience overseeing antifungal and antibacterial agents through all development phases, and is an active contributor to global efforts to enable the development of new agents.
Subscribe to his AMR Solutions Newsletter to learn more about antimicrobial resistance research and development insights and strategies.